Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 159,588 275,693 319,053 656,089
Total Sell Value $13,270,852 $23,760,160 $27,661,182 $61,420,002
Total People Sold 5 6 7 7
Total Sell Transactions 10 21 27 56
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 2582
  Page 25 of 104  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lawlis V Bryan Director   –       •      –    2018-12-27 4 AS $82.53 $177,440 D/D (2,150) 19,160     -
   Lawlis V Bryan Director   –       •      –    2018-12-27 4 OE $14.39 $30,939 D/D 2,150 21,310     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-12-26 4 AS $80.50 $322,000 D/D (4,000) 288,290     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-12-26 4 OE $14.39 $57,560 D/D 4,000 292,290     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-12-14 4 AS $92.64 $185,280 D/D (2,000) 288,290     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-12-14 4 OE $17.86 $35,720 D/D 2,000 290,290     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-12-12 4 AS $93.12 $186,240 D/D (2,000) 288,290     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-12-12 4 OE $17.86 $35,720 D/D 2,000 290,290     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-11-20 4 GD $0.00 $0 I/I 540 181,501     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-11-19 4 GD $0.00 $0 I/I 160 182,041     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2018-11-14 4 AS $91.62 $829,359 D/D (9,000) 49,135     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2018-11-14 4 OE $63.10 $567,900 D/D 9,000 58,135     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-11-02 4 AS $97.88 $146,820 D/D (1,500) 288,290     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-11-02 4 OE $17.86 $26,790 D/D 1,500 289,790     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-11-01 4 AS $92.55 $370,200 D/D (4,000) 288,290     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-11-01 4 OE $14.39 $57,560 D/D 4,000 292,290     -
   Mueller Brian SVP, Corporate Controller   •       –      –    2018-10-31 4 A $68.78 $1,513 D/D 22 12,397     -
   Spiegelman Daniel K EVP, Chief Financial Officer   •       –      –    2018-10-31 4 A $68.78 $12,037 D/D 175 51,245     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-10-30 4 OE $14.39 $14,390 D/D 1,000 288,290     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-10-24 4 OE $14.39 $14,390 D/D 1,000 287,290     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2018-10-03 4 AS $98.98 $98,985 D/D (1,000) 49,135     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-10-03 4 AS $99.36 $149,040 D/D (1,500) 286,290     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2018-10-03 4 OE $17.86 $26,790 D/D 1,500 287,790     -
   Lawlis V Bryan Director   –       •      –    2018-09-27 4 AS $97.93 $210,550 D/D (2,150) 19,160     -
   Lawlis V Bryan Director   –       •      –    2018-09-27 4 OE $14.39 $30,939 D/D 2,150 21,310     -
  2582 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 25 of 104
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us